2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline

C323H199F14N27 — CID 159375804

IUPAC2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline
SMILESFC1(F)c2ccc(-c3cc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3ccc(-c4cc(-c5ccccc5)cc(-c5ccccc5)n4)cc3)cc2-c2cc(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)ccc21.FC1(F)c2ccc(-c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3ccccc3-4)cc2-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2cc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2cc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3c4ccccc4cc4ccccc34)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3cccc4nccnc34)ccc21
InChIInChI=1S/C57H36F2N4.C53H33F2N3.3C45H28F2N4.C42H25F2N3.C36H21F2N5/c58-57(59)50-31-29-45(38-21-25-41(26-22-38)53-36-47(37-13-5-1-6-14-37)35-52(60-53)40-15-7-2-8-16-40)33-48(50)49-34-46(30-32-51(49)57)39-23-27-44(28-24-39)56-62-54(42-17-9-3-10-18-42)61-55(63-56)43-19-11-4-12-20-43;54-53(55)46-29-26-36(37-25-28-42-41-23-13-14-24-45(41)52(48(42)33-37,39-19-9-3-10-20-39)40-21-11-4-12-22-40)31-43(46)44-32-38(27-30-47(44)53)51-57-49(34-15-5-1-6-16-34)56-50(58-51)35-17-7-2-8-18-35;46-45(47)38-23-21-33(41-28-35(29-13-5-1-6-14-29)27-40(48-41)30-15-7-2-8-16-30)25-36(38)37-26-34(22-24-39(37)45)44-50-42(31-17-9-3-10-18-31)49-43(51-44)32-19-11-4-12-20-32;2*46-45(47)37-23-21-33(43-48-39(29-13-5-1-6-14-29)27-40(49-43)30-15-7-2-8-16-30)25-35(37)36-26-34(22-24-38(36)45)44-50-41(31-17-9-3-10-18-31)28-42(51-44)32-19-11-4-12-20-32;43-42(44)36-21-19-30(38-32-17-9-7-15-28(32)23-29-16-8-10-18-33(29)38)24-34(36)35-25-31(20-22-37(35)42)41-46-39(26-11-3-1-4-12-26)45-40(47-41)27-13-5-2-6-14-27;37-36(38)29-16-14-24(26-12-7-13-31-32(26)40-19-18-39-31)20-27(29)28-21-25(15-17-30(28)36)35-42-33(22-8-3-1-4-9-22)41-34(43-35)23-10-5-2-6-11-23/h1-36H;1-33H;3*1-28H;1-25H;1-21H
InChIKeyLKHLHZJFMMHWHW-UHFFFAOYSA-N
MW4724.31 g/mol
LogP81.48
Rot. Bonds40

About 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline

2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline (PubChem CID 159375804) has the molecular formula C323H199F14N27 and a molecular weight of 4724.31 g/mol. Its IUPAC name is 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline.

Molecular Properties

Compound Name2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline
PubChem CID159375804
Molecular FormulaC323H199F14N27
Molecular Weight4724.31 g/mol
Exact Mass4720.62
IUPAC Name2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline
SMILESFC1(F)c2ccc(-c3cc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3ccc(-c4cc(-c5ccccc5)cc(-c5ccccc5)n4)cc3)cc2-c2cc(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)ccc21.FC1(F)c2ccc(-c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3ccccc3-4)cc2-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2cc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2cc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3c4ccccc4cc4ccccc34)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3cccc4nccnc34)ccc21
InChIInChI=1S/C57H36F2N4.C53H33F2N3.3C45H28F2N4.C42H25F2N3.C36H21F2N5/c58-57(59)50-31-29-45(38-21-25-41(26-22-38)53-36-47(37-13-5-1-6-14-37)35-52(60-53)40-15-7-2-8-16-40)33-48(50)49-34-46(30-32-51(49)57)39-23-27-44(28-24-39)56-62-54(42-17-9-3-10-18-42)61-55(63-56)43-19-11-4-12-20-43;54-53(55)46-29-26-36(37-25-28-42-41-23-13-14-24-45(41)52(48(42)33-37,39-19-9-3-10-20-39)40-21-11-4-12-22-40)31-43(46)44-32-38(27-30-47(44)53)51-57-49(34-15-5-1-6-16-34)56-50(58-51)35-17-7-2-8-18-35;46-45(47)38-23-21-33(41-28-35(29-13-5-1-6-14-29)27-40(48-41)30-15-7-2-8-16-30)25-36(38)37-26-34(22-24-39(37)45)44-50-42(31-17-9-3-10-18-31)49-43(51-44)32-19-11-4-12-20-32;2*46-45(47)37-23-21-33(43-48-39(29-13-5-1-6-14-29)27-40(49-43)30-15-7-2-8-16-30)25-35(37)36-26-34(22-24-38(36)45)44-50-41(31-17-9-3-10-18-31)28-42(51-44)32-19-11-4-12-20-32;43-42(44)36-21-19-30(38-32-17-9-7-15-28(32)23-29-16-8-10-18-33(29)38)24-34(36)35-25-31(20-22-37(35)42)41-46-39(26-11-3-1-4-12-26)45-40(47-41)27-13-5-2-6-14-27;37-36(38)29-16-14-24(26-12-7-13-31-32(26)40-19-18-39-31)20-27(29)28-21-25(15-17-30(28)36)35-42-33(22-8-3-1-4-9-22)41-34(43-35)23-10-5-2-6-11-23/h1-36H;1-33H;3*1-28H;1-25H;1-21H
InChIKeyLKHLHZJFMMHWHW-UHFFFAOYSA-N
XLogP81.48
TPSA348.03 Ų
H-Bond Donors
H-Bond Acceptors27
Rotatable Bonds40
Heavy Atoms364
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5004724.31
LogP ≤ 581.48
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1027

Analyze 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

18,19-Diisocyano-10-[4-(trifluoromethyl)phenyl]-3,6,15,17,20,22-hexazahexacyclo[11.10.1.02,7.09,24.014,23.016,21]tetracosa-1,3,5,7,9,11,13(24),14(23),15,17,19,21-dodecaene
CID 58084837
N-[4-[7-[4-[2-fluoro-N-(9,9'-spirobi[fluorene]-4-yl)anilino]phenyl]benzo[k]fluoranthen-12-yl]phenyl]-N-phenylquinazolin-2-amine
CID 89799110
N-[4-[7-[4-[2-fluoro-N-(9,9'-spirobi[fluorene]-4-yl)anilino]phenyl]benzo[k]fluoranthen-12-yl]phenyl]-N-phenylquinoxalin-2-amine
CID 89799114
8-(4,6-Dicyclohexyl-1,3,5-triazin-2-yl)-5-(1,1,2,2,3,3-hexamethylinden-5-yl)-2-(trifluoromethyl)-1,6-naphthyridine
CID 118857470
8-(4,6-Dinaphthalen-1-yl-1,3,5-triazin-2-yl)-5-(4-tricyclo[6.2.1.02,7]undeca-2(7),3,5-trienyl)-2-(trifluoromethyl)-1,6-naphthyridine
CID 130376298
8-(4,6-dicyclohexyl-1,3,5-triazin-2-yl)-5-(1,1,3,3-tetramethyl-2H-inden-5-yl)-2-(trifluoromethyl)-1,6-naphthyridine
CID 130376299
8-[4-[3-[6-(4,6-Diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-5-(4-quinolin-8-ylphenyl)phenyl]phenyl]quinoline
CID 134271792
5-[6-(4,6-Diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline
CID 134271797
4-[6-(4,6-Diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-2-pyridin-2-ylquinoline
CID 134271811
5-[7-(4,6-Diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-2-yl]quinoxaline
CID 134271900
8-[4-[3-[7-(4,6-Diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-2-yl]-5-(4-quinolin-8-ylphenyl)phenyl]phenyl]quinoline
CID 134271902
4-[4-[7-(4,6-Diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-2-yl]phenyl]-2-pyridin-2-ylquinoline
CID 134271919

Frequently Asked Questions

What is the IUPAC name of 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline?
The IUPAC name of 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline (CID 159375804) is 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline.
What is the SMILES notation for 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline?
The canonical SMILES for 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline is FC1(F)c2ccc(-c3cc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3ccc(-c4cc(-c5ccccc5)cc(-c5ccccc5)n4)cc3)cc2-c2cc(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)ccc21.FC1(F)c2ccc(-c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3ccccc3-4)cc2-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2cc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2cc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3c4ccccc4cc4ccccc34)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3cccc4nccnc34)ccc21.
What is the InChIKey of 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline?
The InChIKey is LKHLHZJFMMHWHW-UHFFFAOYSA-N. The full InChI is InChI=1S/C57H36F2N4.C53H33F2N3.3C45H28F2N4.C42H25F2N3.C36H21F2N5/c58-57(59)50-31-29-45(38-21-25-41(26-22-38)53-36-47(37-13-5-1-6-14-37)35-52(60-53)40-15-7-2-8-16-40)33-48(50)49-34-46(30-32-51(49)57)39-23-27-44(28-24-39)56-62-54(42-17-9-3-10-18-42)61-55(63-56)43-19-11-4-12-20-43;54-53(55)46-29-26-36(37-25-28-42-41-23-13-14-24-45(41)52(48(42)33-37,39-19-9-3-10-20-39)40-21-11-4-12-22-40)31-43(46)44-32-38(27-30-47(44)53)51-57-49(34-15-5-1-6-16-34)56-50(58-51)35-17-7-2-8-18-35;46-45(47)38-23-21-33(41-28-35(29-13-5-1-6-14-29)27-40(48-41)30-15-7-2-8-16-30)25-36(38)37-26-34(22-24-39(37)45)44-50-42(31-17-9-3-10-18-31)49-43(51-44)32-19-11-4-12-20-32;2*46-45(47)37-23-21-33(43-48-39(29-13-5-1-6-14-29)27-40(49-43)30-15-7-2-8-16-30)25-35(37)36-26-34(22-24-38(36)45)44-50-41(31-17-9-3-10-18-31)28-42(51-44)32-19-11-4-12-20-32;43-42(44)36-21-19-30(38-32-17-9-7-15-28(32)23-29-16-8-10-18-33(29)38)24-34(36)35-25-31(20-22-37(35)42)41-46-39(26-11-3-1-4-12-26)45-40(47-41)27-13-5-2-6-14-27;37-36(38)29-16-14-24(26-12-7-13-31-32(26)40-19-18-39-31)20-27(29)28-21-25(15-17-30(28)36)35-42-33(22-8-3-1-4-9-22)41-34(43-35)23-10-5-2-6-11-23/h1-36H;1-33H;3*1-28H;1-25H;1-21H.
What are the key properties of 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline?
2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline has a molecular weight of 4724.31 g/mol, XLogP of 81.48, 40 rotatable bonds, 0 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(6-anthracen-9-yl-9,9-difluorofluoren-3-yl)-4,6-diphenyl-1,3,5-triazine;2-[6-(9,9-diphenylfluoren-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-diphenyl-2-pyridinyl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[4-[6-[4-(4,6-diphenyl-2-pyridinyl)phenyl]-9,9-difluorofluoren-3-yl]phenyl]-4,6-diphenyl-1,3,5-triazine;bis(2-[6-(4,6-diphenylpyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenylpyrimidine);5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline is sourced from PubChem (CID 159375804), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).